Watch how we’re harnessing AI at AstraZeneca to help transform cancer care—enabling earlier detection, precise diagnosis and personalised treatment options. By unlocking insights from complex data, we are discovering real-world solutions faster than ever before —making a real-world difference for patients and families. #WhatScienceCanDo
AstraZeneca
Pharmaceutical Manufacturing
Cambridge, Cambridgeshire 3,501,849 followers
About us
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
- Website
-
http://www.astrazeneca.com
External link for AstraZeneca
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Public Company
- Specialties
- Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business
Locations
-
Primary
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge, Cambridgeshire CB2 0AA, GB
-
Astraallen
Sodertalje, Stockholm County 152 57, SE
Employees at AstraZeneca
Updates
-
Driven by our ambition to revolutionise cancer care, we are committed to collaborating with the entire cancer ecosystem to drive changes for patients living with hepatocellular carcinoma (HCC), otherwise known as liver cancer. We recently developed an HCC Patient Charter in partnership with a multidisciplinary group of policymakers, healthcare professionals and patient advocacy groups to address the global need for equitable, comprehensive care. Learn more: https://learn.az/6048AFnJI
-
In celebration of International Day of the Girl and Girls Belong Here, we partnered with Plan International to welcome young women into senior leadership roles across our global workplaces. Throughout the experience they were encouraged to share their views and offer fresh perspectives on the issues that matter most to them – a powerful reminder to open doors for the next generation and show they belong in every decision-making space. #YoungHealthProgramme #GirlsBelongHere #InternationalDayOfTheGirl
-
Breast cancer continues to be a leading cause of female cancer deaths worldwide and an urgent public health concern. Science and innovation can transform cancer care, but lasting progress comes from joining forces across sectors to break down the barriers to care. Learn more about our ambition to work together to eliminate breast cancer as a cause of death. #BreastCancerAwarenessMonth
-
How much do you know about cancer care today? We asked our oncology leaders David Fredrickson and Susan Galbraith if the latest advancements are “fact or fiction.” Watch the video below to find out. #ESMO25
-
On #GlobalPNHAwarenessDay, we’re joining the #RareDisease community around the world to bring attention to paroxysmal nocturnal hemoglobinuria (#PNH). By deepening awareness and understanding of this rare, debilitating hematologic disease, we’re committed to driving earlier diagnoses with the goal of improving outcomes for those living with PNH.
-
-
#BreakingNews We’re proud to announce a historic agreement with President Trump to lower the cost of prescription medicines for American patients while preserving America’s cutting-edge biopharmaceutical innovation. This agreement builds on our commitment to invest $50 billion in US medicines manufacturing and R&D by 2030 and supports our ambition to achieve $80 billion in total revenue by that year as we continue pushing the boundaries of science to deliver life-changing medicines. Learn more ➡️ https://learn.az/6040AQPYq
-
-
#BreakingNews Today we announced plans to invest US$4.5 billion in a new manufacturing facility in Virginia, which includes a proposed $500m increase to enhance manufacturing capabilities across a broader range of medicines, including cancer treatments. This is part of our historic $50 billion investment commitment to US medicines manufacturing and R&D by 2030. The new facility will be at the forefront of technological innovation, creating thousands of jobs and accelerating the development of transformative therapies for patients in the US and around the world. #AZN #WhatScienceCanDo
-
We’re working to advance care for patients living with complex cardiovascular diseases including hypertension. Discover more about our work in this area: https://learn.az/6045AqoE3
-
At #EXPO25, our experts demonstrated how robust global partnerships are accelerating the discovery of new medicines and ultimately delivering better patient outcomes. Lessons from Japan’s approach to universal healthcare and leveraging groundbreaking technology for health continue to inform global action. And worldwide collaborations are propelling progress in oncology, chronic disease prevention, and personalised care—showcasing how innovative technology and dynamic teamwork can reshape healthcare for a healthier future. #TransformingCare #DigitalHealth
-